Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental condition that affects millions of children and adults worldwide, impacting their ability to focus, control impulses, and manage daily activities. Recent data shows that approximately 7 million (11.4%) U.S. children aged 3-17 years have ever been diagnosed with ADHD, according to a national survey of parents using data from 2022. The condition often persists into adulthood, with an estimated 15.5 million U.S. adults (6.0%) having a current ADHD diagnosis based on self-report.

Understanding ADHD across different age groups is crucial for proper diagnosis and treatment. While symptoms manifest differently in children versus adults, early identification and appropriate intervention can significantly improve outcomes throughout life. Research indicates that approximately one half received the diagnosis at age ≥18 years, highlighting the importance of recognizing ADHD symptoms at any life stage.

Table of Contents

  • Statistics on ADHD in Children
  • Signs of ADHD in Children
  • How Treatment for ADHD Can Impact Children
  • ADHD in Adults
  • Treatment Approaches Across Ages
  • Comorbid Conditions
  • Frequently Asked Questions
  • How Therapy Can Help

Statistics on ADHD in Children

The prevalence of ADHD in children has been extensively studied, revealing important demographic patterns and trends. According to recent CDC data:

  • In 2022, an additional 1 million U.S. children aged 3-17 years had ever received an ADHD diagnosis compared to 2016
  • Boys (15%) were more likely to be diagnosed with ADHD than girls (8%)
  • Black children and White children were more often diagnosed with ADHD (both 12%) than Asian children (4%)
  • Overall, non-Hispanic children (12%) were diagnosed with ADHD more often than Hispanic children (10%)

Socioeconomic factors also play a significant role. The prevalence of ADHD decreased as the level of family income increased. Additionally, children with public (14.4%) or private (9.7%) health insurance were more likely to have ADHD than children without insurance (6.3%).

Research shows that early diagnosis is possible, with children ages 5-11 years being less likely than children ages 12-17 years to have ADHD. This suggests that many cases are identified as children progress through school and face increasing academic demands.

Signs of ADHD in Children

ADHD symptoms in children fall into two main categories: inattentive and hyperactive-impulsive. Children may display symptoms from one or both categories.

Inattentive Symptoms:

  • Difficulty sustaining attention in tasks or play
  • Frequently makes careless mistakes
  • Often seems not to listen when spoken to directly
  • Struggles to follow through on instructions
  • Has difficulty organizing tasks and activities
  • Frequently loses items necessary for tasks
  • Easily distracted by extraneous stimuli
  • Forgetful in daily activities

Hyperactive-Impulsive Symptoms:

  • Fidgets with hands or feet, or squirms in seat
  • Leaves seat when remaining seated is expected
  • Runs or climbs excessively in inappropriate situations
  • Has difficulty playing quietly
  • Acts as if "driven by a motor"
  • Talks excessively
  • Blurts out answers before questions are completed
  • Has difficulty waiting turn
  • Interrupts or intrudes on others

About 6 in 10 children had moderate or severe ADHD. Additionally, children with both ADHD and another co-occurring condition, such as behavioral or conduct problems, learning disorders, anxiety, or depression, more often had severe ADHD than children with ADHD without other co-occurring conditions.

How Treatment for ADHD Can Impact Children

Early and appropriate treatment can significantly improve outcomes for children with ADHD. According to recent treatment data from 2022:

  • About half (53.6 percent, 3.4 million) currently take ADHD medication
  • Two out of five (44.4 percent, 2.8 million) received behavioral treatment for ADHD in the past year
  • About one out of three (28.2 percent, 1.8 million) received a combination of ADHD medication and behavioral treatment in the past year
  • About one out of three (30.1 percent, 1.9 million) had not received medication or behavioral treatment

Behavioral Therapy First Approach

Recent research emphasizes the importance of behavioral interventions, particularly for younger children. Behavioral therapy – when used first – was less expensive and more effective than medication in treating children with ADHD. The CDC recommends that for children younger than 6 years old, parent training in behavior management should be tried before prescribing ADHD medication.

Studies show that children who began with the combined approach showed more behavioral issues after medication was withdrawn compared to those who started with behavioral therapy alone. This suggests that "starting with behavioral therapy and then introducing medication could lead to better behavioral outcomes."

School-Based Interventions

Children with ADHD often benefit from school-based support systems. Research demonstrates that there is strong support for behavioral classroom interventions, including the Daily Report Card, and it is strongly recommended that this intervention be initiated for children with ADHD experiencing classroom-based impairment.

ADHD in Adults

ADHD frequently persists into adulthood, though symptoms may present differently. The worldwide prevalence of adult ADHD is 3.1%, with a 95% confidence interval ranging from 2.6% to 3.6%. In the United States, the prevalence is higher, with recent estimates showing approximately 6% of adults have a current ADHD diagnosis.

Adult ADHD Characteristics

Adult ADHD symptoms often manifest as:

  • Inattentive symptoms: Difficulty with time management, disorganization, problems prioritizing tasks, poor planning skills, difficulty multitasking
  • Hyperactive symptoms: Restlessness, excessive talking, difficulty engaging in quiet activities
  • Impulsive symptoms: Impulsive spending, frequent job changes, difficulty in relationships, interrupting others

Approximately one half of adults with ADHD received the diagnosis at age ≥18 years, indicating that many individuals are not diagnosed until adulthood. This late diagnosis can occur because:

  • Symptoms may have been masked by coping strategies
  • High intelligence may have compensated for symptoms
  • Symptoms became more apparent with increased life responsibilities

Treatment Challenges in Adults

Adults with ADHD face unique treatment challenges. Recent data shows that approximately one third of adults with ADHD took a stimulant medication to treat their ADHD in the previous year, 71.5% of whom had difficulty getting their ADHD prescription filled because it was unavailable.

Treatment Approaches Across Ages

Medication Treatment

Stimulant medications remain a first-line treatment for ADHD across age groups. Recent meta-analyses show that medications such as amphetamines, methylphenidate, and atomoxetine improved QoL compared to placebo, with moderate effect sizes.

For adults specifically, stimulants and atomoxetine were the only interventions with evidenced impact on reducing core ADHD symptoms in a 12-week period.

Behavioral and Psychological Interventions

Cognitive-behavioral therapy (CBT) has shown significant efficacy for ADHD treatment:

  • CBT was associated with significant differences in favor of CBT for self-reported ADHD symptoms (SMD −0.84, 95% CI −1.18 to −0.50; 5 studies, 251 participants; moderate-quality evidence; large effect size)
  • CBT with pharmacotherapy was more effective than pharmacotherapy alone for clinician-reported core symptoms (SMD −0.80, 95% CI −1.31 to −0.30; 2 studies, 65 participants; very low-quality evidence; large effect size)

Research indicates that CBT + M is more effective than M in improving adult ADHD symptoms and maintains an advantage for at least 3 months.

Combined Treatment Approaches

The combination of medication and behavioral interventions often yields the best outcomes. For patients with comorbid illnesses, these integrated approaches have demonstrated significant improvements in symptom relief and quality of life enhancement.

Comorbid Conditions

ADHD rarely occurs in isolation. Understanding and addressing comorbid conditions is crucial for effective treatment.

In Children

Many children with ADHD have other disorders as well as ADHD, such as behavior or conduct problems, learning disorders, anxiety, and depression. Specific prevalence rates include:

  • Oppositional Defiant Disorder (34.7%)
  • Behavior Disorders (30.7%)
  • Anxiety Disorders (18.4%)
  • Conduct Disorder (10.7%)

In Adults

Adults with ADHD frequently experience comorbid mental health conditions:

  • 56% of adults with ADHD also have an anxiety disorder
  • 21% of adults with a substance use disorder also have ADHD
  • Research suggests that stress, depression, and anxiety may result from undiagnosed and untreated ADHD

Patients with ADHD and comorbid conditions exhibit greater disease burden and experience reduced treatment effectiveness, making comprehensive assessment and integrated treatment approaches essential.

Frequently Asked Questions

Can ADHD be diagnosed in preschool children?

Yes, ADHD can be diagnosed in children as young as 4 years old. However, diagnosis at this age requires careful evaluation by experienced professionals. For preschoolers, behavioral therapy through parent training is the recommended first-line treatment before considering medication.

Does ADHD affect boys and girls differently?

Yes, there are notable gender differences. Boys are diagnosed with ADHD almost twice as often as girls (15% vs. 8%). However, girls may be underdiagnosed because they often present with inattentive symptoms rather than hyperactive behaviors, which are less disruptive and therefore less likely to be noticed.

What percentage of children with ADHD continue to have symptoms as adults?

Research suggests that ADHD persists into adulthood in a majority of cases. Approximately 60-70% of children with ADHD continue to experience symptoms as adults, though the presentation may change, with hyperactivity often decreasing while inattention and executive function difficulties persist.

Is medication always necessary for ADHD treatment?

No, medication is not always necessary. Treatment should be individualized based on age, symptom severity, and functional impairment. For young children, behavioral therapy is recommended as the first-line treatment. Many individuals benefit from non-medication approaches like behavioral therapy, CBT, organizational skills training, and lifestyle modifications.

Can adults develop ADHD, or is it always present from childhood?

ADHD is a neurodevelopmental disorder that begins in childhood, though symptoms must cause impairment to warrant diagnosis. While adults cannot develop ADHD for the first time, many are diagnosed in adulthood because their symptoms were not recognized earlier or because increased life demands made symptoms more apparent.

How does untreated ADHD affect long-term outcomes?

Untreated ADHD can lead to significant impairments including academic underachievement, employment difficulties, relationship problems, increased risk of accidents, and development of comorbid mental health conditions. Early identification and treatment can help prevent these negative outcomes and improve overall quality of life.

How Therapy Can Help

Finding the right therapeutic support is crucial for managing ADHD effectively. GoodTherapy.org's directory can help you connect with mental health professionals who specialize in ADHD treatment across the lifespan.

For Children and Families:

  • Behavioral parent training specialists
  • Child psychologists experienced in ADHD
  • Family therapists who can address family dynamics
  • School psychologists for educational support

For Adults:

  • Therapists specializing in adult ADHD
  • CBT practitioners with ADHD expertise
  • Psychiatrists for medication management
  • ADHD coaches for practical life skills

When seeking treatment, look for providers who offer evidence-based approaches and have specific experience with ADHD. Many individuals benefit from a combination of therapy, medication (when appropriate), and practical support strategies.

Find a Therapist: Use GoodTherapy's directory to search for ADHD specialists in your area who can provide comprehensive assessment and individualized treatment planning.

References:

  1. American Professional Society of ADHD and Related Disorders (APSARD). (2024). Clinical practice guidelines for adult ADHD (forthcoming). Referenced in Mattingly, G., & Childress, A. (2024). Clinical implications of attention-deficit/hyperactivity disorder in adults. Journal of Clinical Psychiatry, 85(4), 24com15592. https://doi.org/10.4088/JCP.24com15592
  2. Ayano, G., Demelash, S., Gizachew, Y., Tsegay, L., & Alati, R. (2023). The global prevalence of attention deficit hyperactivity disorder in children and adolescents: An umbrella review of meta-analyses. Journal of Affective Disorders, 339, 860-866. https://doi.org/10.1016/j.jad.2023.07.071
  3. Ayano, G., Tsegay, L., Gizachew, Y., et al. (2023). Prevalence of attention deficit hyperactivity disorder in adults: Umbrella review of evidence generated across the globe. Psychiatry Research, 328, 115449. https://doi.org/10.1016/j.psychres.2023.115449
  4. Bellato, A., Perrott, N. J., Marzulli, L., Parlatini, V., Coghill, D., & Cortese, S. (2025). Systematic review and meta-analysis: Effects of pharmacological treatment for attention-deficit/hyperactivity disorder on quality of life. Journal of the American Academy of Child & Adolescent Psychiatry, 64(3), 346-361. https://doi.org/10.1016/j.jaac.2024.05.023
  5. Centers for Disease Control and Prevention. (2024, May 15). Parent training in behavior management for ADHD. https://www.cdc.gov/adhd/treatment/behavior-therapy.html
  6. Centers for Disease Control and Prevention. (2024, October 22). Other concerns and conditions with ADHD. https://www.cdc.gov/adhd/about/other-concerns-and-conditions.html
  7. Centers for Disease Control and Prevention. (2024, November 19). Data and statistics on ADHD. https://www.cdc.gov/adhd/data/index.html
  8. Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD). (2025). General prevalence of ADHD in children and adults. https://chadd.org/about-adhd/general-prevalence/
  9. Danielson, M. L., Claussen, A. H., Bitsko, R. H., Katz, S. M., Newsome, K., Blumberg, S. J., Kogan, M. D., & Ghandour, R. (2024). ADHD prevalence among U.S. children and adolescents in 2022: Diagnosis, severity, co-occurring disorders, and treatment. Journal of Clinical Child & Adolescent Psychology, 53(3), 343-360. https://doi.org/10.1080/15374416.2024.2335625
  10. Dimitrov, L. V., Kaminski, J. W., Holbrook, J. R., et al. (2024). A systematic review and meta-analysis of chemical exposures and attention-deficit/hyperactivity disorder in children. Prevention Science, 25(Suppl 2), 225-248. https://doi.org/10.1007/s11121-023-01601-6
  11. Fei, X., Wang, W., Wang, Y., et al. (2025). Adult ADHD and comorbid anxiety and depressive disorders: A review of etiology and treatment. Frontiers in Psychiatry, 16, 1597559. https://doi.org/10.3389/fpsyt.2025.1597559
  12. Horn, E., Turkheimer, E., Strang, J. F., & Courtet, P. (2025). Psychiatric comorbidity in children and adolescents with ADHD: A systematic review and meta-analysis. Clinical Psychology Review, 108, 102237. https://doi.org/10.1016/j.cpr.2025.102237
  13. Li, Y., & Zhang, L. (2024). Efficacy of cognitive behavioral therapy combined with pharmacotherapy versus pharmacotherapy alone in adult ADHD: A systematic review and meta-analysis. Journal of Attention Disorders, 28(3), 411-428. https://doi.org/10.1177/10870547231214969
  14. Lopez, P. L., Torrente, F. M., Ciapponi, A., et al. (2018). Cognitive-behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database of Systematic Reviews, 3, CD010840. https://doi.org/10.1002/14651858.CD010840.pub2
  15. Nourredine, M., Jurek, L., Salanti, G., et al. (2024). Efficacy of pharmacological interventions for ADHD: Protocol for an updated systematic review and dose-response network meta-analysis. Systematic Reviews, 13, 256. https://doi.org/10.1186/s13643-024-02675-1
  16. Ostinelli, E. G., Spence, C., Dahlen, P., et al. (2025). Comparative efficacy and acceptability of pharmacological, psychological, and neurostimulatory interventions for ADHD in adults: A systematic review and component network meta-analysis. The Lancet Psychiatry, 12(1), 68-80. https://doi.org/10.1016/S2215-0366(24)00360-2
  17. Popit, M., Wiesinger, C., Vogrinc, N., et al. (2024). Prevalence of attention-deficit hyperactivity disorder (ADHD): Systematic review and meta-analysis. European Psychiatry, 67(1), e78. https://doi.org/10.1192/j.eurpsy.2024.1786
  18. Ramos, M., Pelham, W. E., et al. (2024). New study reinforces the benefits of behavioral therapy first for treating kids with ADHD. Evidence-Based Practice in Child and Adolescent Mental Health, 39(4), 412-425. https://doi.org/10.1080/23794925.2024.2389654
  19. Reuben, C., & Elgaddal, N. (2024). Attention-deficit/hyperactivity disorder in children ages 5–17 years: United States, 2020–2022. NCHS Data Brief, No. 499. National Center for Health Statistics. https://www.cdc.gov/nchs/products/databriefs/db499.htm
  20. Soto, E. F., Irwin, L. N., Chan, E. S. M., et al. (2024). Improving the efficacy and effectiveness of evidence-based psychosocial interventions for attention-deficit/hyperactivity disorder (ADHD) in children and adolescents. Translational Psychiatry, 14, 245. https://doi.org/10.1038/s41398-024-02890-3
  21. Staley, B. S., Robinson, L. R., Claussen, A. H., et al. (2024). Attention-deficit/hyperactivity disorder diagnosis, treatment, and telehealth use in adults — National Center for Health Statistics Rapid Surveys System, United States, October–November 2023. MMWR Morbidity and Mortality Weekly Report, 73(40), 890-895. https://doi.org/10.15585/mmwr.mm7340a1
  22. Vidal, R., Bosch, R., Nogueira, M., et al. (2023). Long-term efficacy of a new 6-session cognitive behavioral therapy for adults with attention-deficit/hyperactivity disorder: A randomized, controlled clinical trial. Psychiatry Research, 330, 115642. https://doi.org/10.1016/j.psychres.2023.115642
  23. William, S., Horrocks, M., Richmond, J., Hall, C. L., & French, B. (2024). Experience of CBT in adults with ADHD: A mixed methods study. Frontiers in Psychiatry, 15, 1341624. https://doi.org/10.3389/fpsyt.2024.1341624